Requests that the FDA to revise the Draft Guidance on Cariprazine Hydrochloride, RLD or RS number 204370 on Product-Specific Guidances for Generic Drug Development Database to include the information of cariprazine hydrochloride capsules, 0.5 mg and cariprazine hydrochloride Capsules, 0.75 mg
🏛 Food and Drug Administration (FDA)FDA-2026-P-2443
Documents
2
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
- Other· Mar 10, 2026No comment period